Propantheline bromide: Difference between revisions

Content deleted Content added
m Quick-adding category Bromides (using HotCat)
add drug class infobox parameter
 
(39 intermediate revisions by 24 users not shown)
Line 1:
{{Short description|Drug for functional gastrointestinal disorders}}
{{Refimprove|date=March 2009}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 464216255
| IUPAC_name = ''N''-isopropyl-''N''-methyl-''N''-<nowiki/>{2-[(9''H''-xanthen-9-ylcarbonyl)oxy]ethyl}propan-2-aminium bromide
| image = Proprantheline bromide.svg
<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|monograph|propantheline_bromide}}
| MedlinePlus = a684020
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| class = [[Antimuscarinic]]
 
<!--Identifiers-->
{{drugbox
| CAS_number_Ref = {{cascite|correct|CAS}}
|image = Proprantheline bromide.svg
| CAS_number =298- 50-34-0
|IUPAC_name = ''N''-isopropyl-''N''-methyl-''N''-{2-[(9''H''-xanthen-9-ylcarbonyl)oxy]ethyl}propan-2-aminium bromide
| ATC_prefix = A03
|CAS_number=298-50-0
| ATC_suffix = AB05
|CAS_supplemental={{CAS|50-34-0}}
| PubChem = 9279
|ATC_prefix=A03
| IUPHAR_ligand = 329
|ATC_suffix=AB05
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
|PubChem = 9279
| DrugBank =APRD00177 DB00782
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
|C=23|H=30|N=1|O=3
| ChemSpiderID = 8922
|molecular_weight=368.489 g/mol
| UNII_Ref = {{fdacite|correct|FDA}}
|bioavailability=
| UNII = UX9Z118X9F
|protein_bound=
| ChEMBL_Ref = {{ebicite|correct|EBI}}
|metabolism=
| ChEMBL = 1240
|elimination_half-life=
| KEGG_Ref = {{keggcite|changed|kegg}}
|excretion=
| KEGG = D00481
|pregnancy_AU=<!-- A / B1 / B2 / B3 / C / D / X -->
<!--Chemical data-->
|pregnancy_US=<!-- A / B / C / D / X -->
| C=23 | H=30 | N=1 | O=3
|pregnancy_category=
| smiles = [Br-].O=C(OCC[N+](C(C)C)(C(C)C)C)C2c3c(Oc1c2cccc1)cccc3
|legal_AU=<!-- Unscheduled / S2 / S4 / S8 -->
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
|legal_UK=<!-- GSL / P / POM / CD -->
| StdInChI = 1S/C23H30NO3.BrH/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22;/h6-13,16-17,22H,14-15H2,1-5H3;1H/q+1;/p-1
|legal_US=<!-- OTC / Rx-only -->
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
|legal_status=
| StdInChIKey = XLBIBBZXLMYSFF-UHFFFAOYSA-M
|routes_of_administration=
}}
'''Propantheline bromide''' ([[International Nonproprietary Name|INN]]) is an [[antimuscarinic]] agent used for the treatment of excessive sweating ([[hyperhidrosis]]), cramps or spasms of the stomach, intestines (gut) or bladder, and involuntary urination ([[enuresis]]). It can also be used to control the symptoms of [[irritable bowel syndrome]] and similar conditions. This agent can also be used for patients who experience intense GI symptoms while tapering off of [[Tricyclic antidepressant|TCAs]].
<ref>{{citebookcite book|title=Female Urology, Urogynecology, and Voiding Dysfunction|first1= Sandipvauthors P.|last1= Vasavada|first2= Rodney|last2=SP, Appell|first3= Peter K.|last3=R, Sand|first4= Shlomo|last4=PK, Raz S |publisher=Informa Health Care|year= 2004|ISBN=08247542630-8247-5426-3}}</ref>
 
==Indications==
Line 33 ⟶ 50:
==Adverse effects==
[[Adverse drug reaction|Side effects]] include [[tachycardia]], [[constipation]], [[photophobia|hypersensitivity to light]], dry mouth, and [[urinary retention]].
This can also be prescribed by dentists for certain patients who salivate excessively. By takinggiving this medication it becomes easier to do "dry" dentistry.
 
==Mechanism of action==
Line 39 ⟶ 56:
 
==References==
{{refsreflist}}
 
{{Drugs for functional gastrointestinal disorders}}
{{Muscarinic acetylcholine receptor modulators}}
 
[[Category:Muscarinic antagonists]]
[[Category:Quaternary ammonium compounds]]
[[Category:Bromides]]
[[Category:Carboxylate esters]]
 
[[Category:Xanthenes]]
 
{{pharma-stub}}